CNO Financial Group, Inc. (CNO) Bundle
You're looking at CNO Financial Group, Inc. and trying to figure out if their recent momentum is real or just a flash, especially with all the noise in the market. Honestly, the Q3 2025 numbers were defintely a strong beat, showing the core business is working: they posted revenue of $1.19 billion, significantly surpassing the consensus, and net operating income (the non-GAAP earnings per share) hit $1.29, which was a massive beat over the $0.95 forecast. Look, the sales engine is running hot with total new annualized premiums up 26%, plus the operating return on equity (ROE) is solid at 12.1%. But here's the quick math on the risk: you can't ignore the interest rate sensitivity in their fixed indexed annuities, which created a $79.7 million drag on Q1 2025 earnings due to embedded derivatives (complex financial instruments used to hedge risk), so we need to see if that non-economic volatility continues to mask the underlying strength that drove the book value per diluted share to $38.10 as of September 30, 2025.
Revenue Analysis
You need a clear picture of where CNO Financial Group, Inc. (CNO) is actually making its money, especially with the market volatility we've seen. The direct takeaway is that while the total trailing-twelve-months (TTM) revenue is slightly down, the core insurance sales-New Annualized Premiums (NAP)-are showing strong double-digit growth in 2025, which is the key metric for future profitability.
For the fiscal year 2025, CNO's TTM revenue as of September 30, 2025, stands at approximately $4.44 billion. This figure represents a slight year-over-year decline of about 1.80%, but that drop is largely due to non-core, non-economic accounting impacts common in the insurance sector, not a failure in selling policies. The third quarter of 2025 alone saw sales of nearly $1.19 billion, beating analyst estimates by over 22%. That's a solid beat.
Breakdown of Primary Revenue Sources
CNO's revenue is a mix, but the vast majority comes from its core insurance operations, which is what you want to see for an insurance company. Net premiums earned-the cornerstone of their business-have historically contributed around 68.1% of total revenue. The rest is primarily net investment income and fee income.
The product mix is focused on the middle-income pre-retiree and retiree market, primarily through three offerings:
- Life Insurance: A core product, with Total Life NAP up 32% in Q3 2025.
- Health Insurance: Total Health NAP saw a 20% increase in Q3 2025, driven by a particularly strong performance in Medicare Supplement plans.
- Annuities: Annuity collected premiums were up 19% in Q2 2025, reflecting a strong interest in retirement savings products in the current interest rate environment.
Segment Contribution and Growth Trends
The company operates mainly through two divisions, and both are showing real momentum in sales growth, which ultimately feeds the revenue line. This tells us the distribution model is working. The Worksite Division and the Consumer Division are both delivering.
Here's the quick math on sales growth (New Annualized Premiums) for the first nine months of 2025:
| Division | Q3 2025 NAP Growth (YoY) | Q2 2025 NAP Growth (YoY) |
|---|---|---|
| Consumer Division | 27% | 17% |
| Worksite Division | 20% | 16% |
The Worksite Division, which sells insurance products through employers, is showing a consistent, strong double-digit increase in NAP. Also, the Consumer Division is seeing massive traction in its direct-to-consumer channel, where digital sales surged by 39% in Q2 2025, now accounting for 30% of those transactions. That's a significant shift in distribution efficiency.
Significant Changes in Revenue Mix
The most important near-term change is CNO's strategic exit from the non-core fee services side of the Worksite business, which was announced in Q3 2025. This business, acquired in 2019 and 2021, was underperforming and contributed only about $30 million annually in fee revenue, which is less than 1% of total revenue. The exit will reduce a pre-tax annual loss of roughly $20 million, so this is a clear move to simplify the model and focus on the higher-margin insurance products. You are defintely seeing management prioritize profitability over top-line fluff. For a deeper dive into who is betting on this strategy, you should read Exploring CNO Financial Group, Inc. (CNO) Investor Profile: Who's Buying and Why?
Profitability Metrics
The core takeaway for CNO Financial Group, Inc. (CNO) is that its operating profitability is solid and expanding, even as non-economic market volatility weighs on reported net income. The company's trailing twelve-month (TTM) revenue as of November 2025 stands at $4.38 Billion USD, and management is focused on translating that top-line figure into higher shareholder returns by improving efficiency.
Looking at the margins, CNO Financial Group's current net profit margin is approximately 6.8%, a noticeable improvement from 6.1% last year. This figure is what you take home, but it can be noisy. For instance, the third quarter of 2025 (3Q25) saw reported net income of only $23.1 million, heavily impacted by non-economic accounting adjustments related to market volatility.
The clearer picture comes from net operating income, which strips out those market-driven swings. In 3Q25, CNO Financial Group's net operating income was a much healthier $127.2 million. This operational strength is what drives the future: analysts project the net profit margin will expand to 10.1% within three years, defintely a target worth watching.
When you compare CNO Financial Group to its peers, the operational efficiency shines. The company's TTM operating return on equity (ROE)-a key measure of how well a company uses shareholder money to generate profit-was 11.2% as of September 30, 2025. This figure comfortably outpaces the Life & Health Insurance sector average, which typically hovers around 10%.
Here's the quick math on the trend: the company is currently achieving an earnings growth of 10.3%, a complete reversal from the previous five-year trend that saw an annual decline of 9.6%. This shift is why management is confident, raising their run-rate operating ROE target for 2025 to around 10.5%.
Operational efficiency is the engine behind this margin expansion. CNO Financial Group is aggressively managing costs and driving revenue through modern channels.
- Digital leads are up 39% year-over-year, lowering acquisition costs.
- Worksite Division operations are being streamlined by exiting the fee services business.
- Expanding underwriting margins are consistently supporting the momentum.
Debt vs. Equity Structure
You want to know if CNO Financial Group, Inc. (CNO) is leaning too heavily on debt to fuel its growth. The short answer is that while their debt-to-equity ratio is higher than the industry average, management has been actively de-risking and reducing their leverage, which is a defintely positive sign for investors.
As of the third quarter of 2025, CNO Financial Group, Inc.'s debt structure is predominantly long-term. The company reported a total long-term debt and capital lease obligation of approximately $4.05 billion as of September 30, 2025. This figure reflects a concerted effort to manage their balance sheet, particularly after a key repayment earlier in the year.
The core metric to watch here is the Debt-to-Capital ratio, which measures debt as a percentage of total capital (debt plus equity). CNO Financial Group, Inc.'s GAAP Debt-to-Capital ratio stood at a manageable 33.8% at the end of Q3 2025, a significant drop from 42.2% at the end of 2024. This reduction was primarily driven by the strategic repayment of the company's 2025 Notes in the second quarter of the year.
Here's the quick math on how CNO Financial Group, Inc. stacks up against the sector:
- CNO Financial Group, Inc.'s Debt-to-Equity (D/E) Ratio: Approximately 1.50.
- Life & Health Insurance Industry Average D/E Ratio: Approximately 0.6264.
To be fair, a D/E of 1.50 suggests CNO Financial Group, Inc. uses more debt relative to shareholder equity than the typical life and health insurance peer, but for a financial services company with stable cash flows, this is often considered within a reasonable range. The downward trend in the Debt-to-Capital ratio is the more important signal right now.
The company's financing strategy has been clear: refinance existing debt to manage maturity risk and maintain a strong balance sheet. For instance, CNO Financial Group, Inc. issued $700 million of 6.45% senior unsecured notes due in 2034. The proceeds from this issuance were used to repay the $500 million, 5.25% senior notes that were due in 2025, effectively extending the maturity profile and locking in a rate for a longer term. This is smart treasury management.
The market views this structure as stable. CNO Financial Group, Inc. maintains an investment-grade rating from all four major credit rating agencies. AM Best, for example, assigned a Long-Term Issue Credit Rating of 'bbb' (Good) to the new 2034 notes, with a stable outlook. This investment-grade status is crucial as it keeps borrowing costs low and signals financial strength.
The balance between debt and equity is currently tilted toward responsible debt management coupled with capital return to shareholders. In Q3 2025 alone, CNO Financial Group, Inc. repurchased 1.6 million common shares for $60.0 million and paid dividends totaling $16.4 million. This shows the company is confident enough in its cash flow and capital position to return significant value to equity holders while simultaneously reducing its overall leverage ratios. You can read more on their core strategy here: Mission Statement, Vision, & Core Values of CNO Financial Group, Inc. (CNO).
The table below summarizes the key leverage metrics as of Q3 2025:
| Metric | Value (Q3 2025) | Context |
|---|---|---|
| Long-Term Debt | $4.05 billion | Primary debt component. |
| GAAP Debt-to-Capital Ratio | 33.8% | Down from 42.2% at 12/31/2024. |
| Debt-to-Total Capital (Excl. AOCI) | 26.4% | A non-GAAP measure showing lower leverage. |
| Life & Health Industry Avg. D/E | 0.6264 | CNO's D/E of 1.50 is higher than this benchmark. |
Liquidity and Solvency
You're looking at CNO Financial Group, Inc. (CNO) and wondering if they have the cash to cover their near-term obligations, which is the core of liquidity analysis. For an insurance holding company like CNO, traditional liquidity metrics like the current and quick ratios often look low, and that's defintely the case here. You need to look past the low numbers and focus on the quality of their investment portfolio and holding company cash.
As of a recent filing, CNO Financial Group, Inc.'s Current Ratio and Quick Ratio both stood at approximately 0.17. This is typical for a financial services firm because their largest liabilities-policy reserves-are long-term, while their assets are primarily long-term investments. The ratios tell you they don't keep a ton of cash on hand to pay every immediate liability, but that's by design in this sector. The real strength lies in their capital position, which management explicitly stated remains above target levels as of the third quarter of 2025.
Holding Company Cash and Working Capital Trends
The key to CNO's financial flexibility is the unrestricted cash and investments held at the parent holding company level. This is the capital available for share repurchases, dividends, and strategic investments. The trend here shows a significant shift, which you need to understand:
- Unrestricted cash at September 30, 2025: $193.7 million
- Unrestricted cash at December 31, 2024: $372.5 million
Here's the quick math: that's a drop of nearly $178.8 million in nine months. This isn't necessarily a red flag, but a clear action signal. This cash was largely used for capital deployment, evidenced by the $310 million returned to shareholders year-to-date in 2025. They're actively managing their capital structure, not hoarding cash.
Cash Flow Statement Overview
When assessing liquidity, cash flow from operations (CFFO) is your lifeblood. For CNO, the cash generation remains strong, though quarterly figures can fluctuate due to the nature of insurance accounting and investment timing. Look at the quarterly CFFO figures for the first half of 2025:
| Period | Net Income (GAAP) | Net Operating Income (Non-GAAP) | Cash from Operations (CFFO) |
|---|---|---|---|
| Q3 2025 | $23.1 million | $127.2 million | N/A (Focus on Operating Income) |
| Q2 2025 | N/A | N/A | $23.8 million |
| Q1 2025 | $13.7 million | $81.1 million | $166.1 million |
The difference between Net Income and Net Operating Income (NOI) is crucial; NOI strips out non-economic accounting impacts from market volatility, giving you a cleaner view of the core business performance. The Q3 2025 NOI of $127.2 million shows the underlying business is generating solid earnings.
On the financing side, CNO paid out $16.4 million in common stock dividends in Q3 2025 alone. The strategic move of executing a second reinsurance transaction with their Bermuda affiliate, reinsuring $1.8 billion of inforce supplemental health statutory reserves, is an active measure to manage capital and optimize their balance sheet, which is a major investing/financing action for an insurer. This is how they ensure long-term solvency while maintaining strong shareholder returns.
If you want to dig deeper into the company's long-term vision that drives these capital allocation decisions, you can review their Mission Statement, Vision, & Core Values of CNO Financial Group, Inc. (CNO).
Valuation Analysis
You're looking at CNO Financial Group, Inc. (CNO) and asking the core question: is the stock priced fairly, or is there a disconnect between its market value and its true economic value? As a seasoned analyst, I see a picture of a company trading at a modest premium to its book value but still looking reasonable when stacked against its earnings power, suggesting it's currently in the Breaking Down CNO Financial Group, Inc. (CNO) Financial Health: Key Insights for Investors sweet spot of being fairly to slightly undervalued.
The market's current assessment, as of November 2025, places CNO Financial Group, Inc.'s valuation metrics in a healthy range. The key is to see how these ratios compare to the sector average, which is typically higher for life and health insurers with stable earnings. Here's the quick math on the core multiples for the 2025 fiscal year:
- Price-to-Earnings (P/E) Ratio: At around 13.84, CNO is trading at a conservative multiple of its earnings. For context, the broader market is often higher, so this suggests its earnings power isn't fully priced in.
- Price-to-Book (P/B) Ratio: This metric sits at approximately 1.51. This means the stock trades at a 51% premium to its net asset value (book value), which is typical for a profitable insurer with a strong return on equity.
- Enterprise Value-to-EBITDA (EV/EBITDA) Ratio: The EV/EBITDA of roughly 6.51 shows the company's total value (equity plus debt, less cash) is quite low relative to its operating cash flow (Earnings Before Interest, Taxes, Depreciation, and Amortization). This is defintely a value signal.
Looking at the stock price trend, CNO Financial Group, Inc. has shown solid momentum. The stock has traded in a 52-week range between a low of $34.63 and a high of $43.20. As of mid-November 2025, the stock is trading near the upper end of that range, around $41.18, reflecting a year-to-date gain of about 10.5%. This upward movement, especially following a strong third-quarter 2025 earnings beat, suggests increasing investor confidence.
For income-focused investors, the dividend profile is attractive and sustainable. CNO Financial Group, Inc. pays an annual dividend of $0.68 per share, translating to a dividend yield of about 1.65%. The most important number here is the dividend payout ratio, which is estimated at a healthy 17.75% for the current year. This low ratio means the company is paying out less than a fifth of its earnings as dividends, leaving plenty of room for reinvestment, share buybacks, and future dividend increases. They just announced a quarterly dividend of $0.17 per share to be paid in December 2025.
The Wall Street consensus leans toward a positive outlook. Analysts currently assign CNO Financial Group, Inc. a consensus rating of Moderate Buy. The average target price is set at $43.60. What this estimate hides, however, is the split: the consensus is based on three 'Buy' ratings and three 'Hold' ratings. No major analyst has a 'Sell' rating, so the risk of a sharp downside re-rating appears low right now. The overall sentiment suggests a modest upside of about 6% from the current price, but the low valuation multiples suggest the potential for a larger re-rating if growth accelerates.
| Valuation Metric | FY 2025 Value | Interpretation |
|---|---|---|
| P/E Ratio | 13.84 | Conservative relative to the broad market. |
| P/B Ratio | 1.51 | Modest premium to net asset value. |
| EV/EBITDA Ratio | 6.51 | Low, suggesting good operating cash flow value. |
| Dividend Yield | 1.65% | Solid income stream. |
| Payout Ratio (Est.) | 17.75% | Highly sustainable dividend. |
| Analyst Target Price | $43.60 | Implies moderate upside from current price. |
Risk Factors
You're looking at CNO Financial Group, Inc. (CNO) and wondering what could derail their solid 2025 performance. The direct takeaway is this: while their core insurance business is strong, the company faces significant market volatility risks in its investment portfolio and competitive pressure that just forced a major strategic exit. You need to focus on their capital buffer and how they manage interest rate swings.
From my perspective, having watched these cycles for two decades, the biggest near-term risks are less about their ability to sell policies-which is defintely strong, with total new annualized premiums up 26% in Q3 2025-and more about the non-operating, market-driven impacts. The company's net income dropped in Q1 2025 due to non-economic accounting impacts from market volatility, even as operating income rose. That's the noise you have to filter out, but it's still real risk.
Here are the key risks CNO Financial Group, Inc. (CNO) is navigating, based on their 2025 filings:
- Market and Interest Rate Risk: Changes in interest rates directly impact CNO's massive investment portfolio and policyholder behavior. For example, a sharp rise in rates could lead to increased policy surrenders, reducing their asset base. Plus, persistent inflation threatens both sales and the accuracy of their long-term pricing models.
- Investment Portfolio Risk: CNO's portfolio is concentrated, with 91% in high-quality fixed maturities and mortgage loans. While this is generally a conservative stance, it still exposes them to credit risk and market volatility. As of September 30, 2025, their fair value of available-for-sale fixed maturities was $23,405.3 million, sitting below the amortized cost of $25,219.3 million, creating net unrealized losses.
- Operational and Technology Risk: Like any large financial institution, CNO Financial Group, Inc. (CNO) faces cybersecurity threats and reliance on third-party vendors. They are actively investing in technology, including AI and automation, but this also introduces new risks that need careful management.
The recent earnings reports highlight two very concrete strategic and financial risks that have already materialized. First, CNO recorded a significant non-operating impairment of $96.7 million on goodwill and intangibles in Q3 2025, tied to competitive challenges in acquired businesses. Second, they decided to exit the worksite fee services business entirely, a segment that was contributing a pre-tax annual loss of about $20 million. This exit is smart, but it comes with a price tag-expected exit charges of $15 million to $20 million in Q4 2025.
To be fair, CNO isn't just sitting still; they are taking clear, decisive action to mitigate these risks and improve future returns. They are focused on capital strength and strategic portfolio management. Here's the quick math on their capital buffer:
| Mitigation Metric | 2025 Target/Actual (Q3) | Impact |
|---|---|---|
| Consolidated Statutory RBC Ratio | Estimated 380% (Q3 2025) | Well above the target of 375%, showing a strong capital buffer. |
| Holding Company Unrestricted Cash | $193.7 million (Q3 2025) | Above the minimum target of $150 million, providing liquidity for operations and shareholder returns. |
| Debt-to-Total Capital Ratio (GAAP) | 33.8% (Q3 2025) | Outside the target range of 25% to 28%, but an improvement from 42.2% at year-end 2024. |
Their strategic moves, like the second reinsurance transaction with their Bermuda affiliate and the fee services exit, are projected to accelerate their operating Return on Equity (ROE) improvement by an extra 50 basis points through 2027. That's a clear action with a measurable financial goal. They're also raising their full-year 2025 excess cash flow guidance to the holding company to a range of $365 million to $385 million, up significantly from the prior $200 million to $250 million range. This excess cash is the ultimate safety net and fuel for future growth or buybacks. You can read more about what drives their long-term planning in their Mission Statement, Vision, & Core Values of CNO Financial Group, Inc. (CNO).
Growth Opportunities
You want to know where CNO Financial Group, Inc. (CNO) is headed, and the short answer is that their growth story is less about massive market expansion and more about high-margin efficiency and demographic tailwinds. They are laser-focused on the underserved middle-income market, and their 2025 results show this strategy is paying off with strong production and a clear path to margin expansion.
Key Growth Drivers: Digital and Demographics
The core of CNO's future growth rests on two pillars: America's aging population and their own digital transformation. The $70 trillion global retirement savings gap is a structural tailwind for their business. Plus, CNO is defintely capitalizing on this demand by aggressively moving into digital channels.
- Digital Sales Surge: Direct-to-consumer digital leads grew by 39% year-over-year in Q2 2025, now accounting for 30% of their business-to-consumer transactions. This shift lowers customer acquisition costs, a huge win for long-term profitability.
- Product Momentum: The company is seeing double-digit growth across key lines. In Q2 2025, annuity collected premiums surged 19%, and life insurance sales rose 20%. This is not just a one-off; it marks their twelfth consecutive quarter of sustained sales momentum.
- Medicare Supplement Expansion: CNO is proactively capturing the health needs of retirees, signaled by a 10% Medicare Supplement rate filing in 2025. This is a smart move to leverage a guaranteed growth market.
Future Projections and Strategic Initiatives
Management is not shy about their targets, and their financial guidance for 2025 reflects a focus on per-share earnings growth, even as overall revenue growth moderates. To be fair, this is a common, shareholder-friendly tactic in the insurance space.
The company is on track to deliver full-year 2025 operating earnings per share (EPS) in the range of $3.70 to $3.90. This is supported by their capital return strategy, which is a major lever for boosting EPS. In Q2 2025 alone, CNO repurchased $100 million of common stock, and the share count is projected to drop by over 6% annually over the next three years. That aggressive buyback pace amplifies your return as a shareholder.
| Key Financial Target | 2025 Target/Result | Growth Driver |
|---|---|---|
| Q2 2025 Revenue | $1.15 billion | Strong production, 53.79% above estimates |
| Full-Year Operating EPS Target | $3.70 - $3.90 | Share repurchases and margin expansion |
| 2025 Operating ROE Target | 10.5% | Operational efficiency, above sector average |
| Q2 2025 Total New Annualized Premiums (NAP) Growth | 17% | Digital channel and Worksite division growth |
| Client Assets in Brokerage and Advisory Growth | 27% (YoY in Q2 2025) | Shift to asset-light products |
Competitive Advantages and Partnerships
CNO's primary competitive advantage is its niche focus on middle-income America, a segment often overlooked by megacap insurers. This focus, combined with a hybrid captive-agent distribution model, provides a unique moat.
The company's strategic initiatives also include a push into asset-light products, such as advisory and brokerage services, which saw a 27% year-on-year increase in client assets. This diversification broadens the revenue mix and acts as a buffer against margin pressure from traditional insurance lines. Their mission is clear: Mission Statement, Vision, & Core Values of CNO Financial Group, Inc. (CNO). They are also committed to improving their run-rate operating Return on Equity (ROE) by 150 basis points through 2027. That's a strong commitment to efficiency.
Here's the quick math: A 10.5% ROE target for 2025, which is already above the typical sector average of 10%, shows their confidence in maintaining an operational edge.
Finance: Monitor the quarterly share repurchase pace to confirm the projected 6% annual share count reduction is on track.

CNO Financial Group, Inc. (CNO) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.